These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 23473678)

  • 1. In vivo antitumour activity of amphiphilic silicon(IV) phthalocyanine with axially ligated rhodamine B.
    Zhao Z; Gambari R; Lee KK; Kok SH; Wong RS; Lau FY; Tang JC; Lam KH; Cheng CH; Hau DK; Chui CH; Wong WY; Wong WK
    Bioorg Med Chem Lett; 2013 Apr; 23(8):2373-6. PubMed ID: 23473678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly selective mitochondria-targeting amphiphilic silicon(IV) phthalocyanines with axially ligated rhodamine B for photodynamic therapy.
    Zhao Z; Chan PS; Li H; Wong KL; Wong RN; Mak NK; Zhang J; Tam HL; Wong WY; Kwong DW; Wong WK
    Inorg Chem; 2012 Jan; 51(2):812-21. PubMed ID: 22191427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitization of Hep3B hepatoma cells to cisplatin and doxorubicin by corilagin.
    Gambari R; Hau DK; Wong WY; Chui CH
    Phytother Res; 2014 May; 28(5):781-3. PubMed ID: 23913631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumour effects of tetrazanbigen against human hepatocellular carcinoma QGY-7701 through inducing lipid accumulation in vitro and in vivo.
    Zheng X; Li W; Lan Z; Yang X; Li L; Yuan Y; Xia Z; Chen X; Zhang X; Yu Y
    J Pharm Pharmacol; 2015 Nov; 67(11):1593-602. PubMed ID: 26245909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer activity and mechanisms of diacetyldianhydrogalactitol on hepatoma QGY-7703 cells.
    Zhang XY; Lian Yan X; Guo W; Xu B; Li M; Zhou Y; Rong Cui J
    Anticancer Drugs; 2009 Nov; 20(10):926-31. PubMed ID: 19741503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BND-12, a novel nonhaematotoxic naphthalimide derivative, inhibits tumour growth and metastasis of hepatocellular carcinoma.
    Xie SQ; Li Q; Zhang YH; Li Z; Zhao J; Wang CJ
    J Pharm Pharmacol; 2012 Oct; 64(10):1483-90. PubMed ID: 22943179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel antitumor indolizino[6,7-b]indoles with multiple modes of action: DNA cross-linking and topoisomerase I and II inhibition.
    Chaniyara R; Tala S; Chen CW; Zang X; Kakadiya R; Lin LF; Chen CH; Chien SI; Chou TC; Tsai TH; Lee TC; Shah A; Su TL
    J Med Chem; 2013 Feb; 56(4):1544-63. PubMed ID: 23360284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A general approach to spirolactonized Si-rhodamines.
    Wang B; Chai X; Zhu W; Wang T; Wu Q
    Chem Commun (Camb); 2014 Nov; 50(92):14374-7. PubMed ID: 25298124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation.
    Zhao P; Chen L; Li LH; Wei ZF; Tong B; Jia YG; Kong LY; Xia YF; Dai Y
    BMC Cancer; 2014 Dec; 14():987. PubMed ID: 25527123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abrogation of constitutive STAT3 activity sensitizes human hepatoma cells to TRAIL-mediated apoptosis.
    Kusaba M; Nakao K; Goto T; Nishimura D; Kawashimo H; Shibata H; Motoyoshi Y; Taura N; Ichikawa T; Hamasaki K; Eguchi K
    J Hepatol; 2007 Oct; 47(4):546-55. PubMed ID: 17602782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Spectral properties, photodynamic anticancer activity and the interaction with albumin of silicon phthalocyanine axially modified by pyrimidine derivatives].
    Shen XM; Jiang XJ; Zhu YJ; Zhang HH; Huang JD
    Guang Pu Xue Yu Guang Pu Fen Xi; 2013 Aug; 33(8):2148-52. PubMed ID: 24159865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudolaric acid B, a novel microtubule-destabilizing agent that circumvents multidrug resistance phenotype and exhibits antitumor activity in vivo.
    Wong VK; Chiu P; Chung SS; Chow LM; Zhao YZ; Yang BB; Ko BC
    Clin Cancer Res; 2005 Aug; 11(16):6002-11. PubMed ID: 16115945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Furanylazaindoles: potent anticancer agents in vitro and in vivo.
    Lee HY; Pan SL; Su MC; Liu YM; Kuo CC; Chang YT; Wu JS; Nien CY; Mehndiratta S; Chang CY; Wu SY; Lai MJ; Chang JY; Liou JP
    J Med Chem; 2013 Oct; 56(20):8008-18. PubMed ID: 24106982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary detection of the anti‑tumour activity of indoline‑2,3‑dione derivative DH‑12a targeting aminopeptidase N.
    Cui DX; Wang XJ; Zhang XR; Zhao TK; Guo XX; Liu SM; Wang B; Ma WQ; Gao ZQ
    Mol Med Rep; 2014 Nov; 10(5):2681-8. PubMed ID: 25216231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The unprecedented J-aggregate formation of rhodamine moieties induced by 9-phenylanthracenyl substitution.
    Kim S; Fujitsuka M; Tohnai N; Tachikawa T; Hisaki I; Miyata M; Majima T
    Chem Commun (Camb); 2015 Jul; 51(58):11580-3. PubMed ID: 26095853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pH-responsive fluorescence probe and photosensitiser based on a tetraamino silicon(IV) phthalocyanine.
    Jiang XJ; Lo PC; Yeung SL; Fong WP; Ng DK
    Chem Commun (Camb); 2010 May; 46(18):3188-90. PubMed ID: 20424769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel synthetic compound exerts effective anti-tumour activity in vivo via the inhibition of tubulin polymerisation in A549 cells.
    Yan J; Pang Y; Sheng J; Wang Y; Chen J; Hu J; Huang L; Li X
    Biochem Pharmacol; 2015 Sep; 97(1):51-61. PubMed ID: 26212540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo anti-tumour activity of corilagin on Hep3B hepatocellular carcinoma.
    Hau DK; Zhu GY; Leung AK; Wong RS; Cheng GY; Lai PB; Tong SW; Lau FY; Chan KW; Wong WY; Lam KH; Cheng CH; Cheung F; Chui CH; Gambari R; Fong DW
    Phytomedicine; 2010 Dec; 18(1):11-5. PubMed ID: 21036022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small molecule antagonists of Tcf4/beta-catenin complex inhibit the growth of HCC cells in vitro and in vivo.
    Wei W; Chua MS; Grepper S; So S
    Int J Cancer; 2010 May; 126(10):2426-36. PubMed ID: 19662654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of pyridocarbazole and benzopyridoindole derivatives that inhibit protein kinase CK2.
    Prudent R; Moucadel V; Nguyen CH; Barette C; Schmidt F; Florent JC; Lafanechère L; Sautel CF; Duchemin-Pelletier E; Spreux E; Filhol O; Reiser JB; Cochet C
    Cancer Res; 2010 Dec; 70(23):9865-74. PubMed ID: 21118972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.